Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
13/05/2026 13:13
May 13 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA PHARMACEUTICALS HOLDINGS INC - TO BE DELISTED FROM NASDAQ; TRADING SUSPENDED AS OF MAY 14, 2026 - SEC FILING REVIVA PHARMACEUTICALS HOLDINGS INC - TO TRADE ON OTCQB VENTURE MARKET UNDER SYMBOL 'RVPH' FROM MAY 14, 2026 - SEC FILING Further company coverage: RVPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture